IP Library Patent Application 11756973
Patent Application
App. No. 11/756,973

Diffractive Intraocular Lens

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/756,973
Abstract

An IOL, comprising a first diffractive region, and a second diffractive region having a power of a different magnitude than the first diffractive region, the first region adapted to diffract substantially all light at a first selected wavelength projected therethrough into a single order of diffraction, and the second region adapted to diffract substantially all light at a second selected wavelength projected therethrough into a single order of diffraction.

Claims (19)

1 . An IOL, comprising:

a first diffractive region; and

a second diffractive region having a power of a different magnitude than the first diffractive region, the first region adapted to diffract substantially all light at a first selected wavelength projected therethrough into a single non-zero order of diffraction, and the second region adapted to diffract substantially all light at a second selected wavelength projected therethrough into a single non-zero order of diffraction.

2 . The IOL of claim 1 , further comprising a third diffractive region having a power of different magnitude than the first and the second regions, adapted to diffract substantially all light at a third selected wavelength projected therethrough into a corresponding single non-zero order of diffraction.

3 . The IOL of claim 1 , wherein the first region and the second region project light into corresponding first orders of diffraction.

4 . The IOL of claim 1 , wherein the first and second regions are disposed concentrically.

5 . The IOL of claim 1 , wherein the IOL comprises one or more haptics.

6 . The IOL of claim 1 , wherein the IOL is made of a material comprising at least one of silicone, PMMA, foldable hydrophilic acrylic and foldable hydrophobic acrylic.

7 . The IOL of claim 4 , further comprising a third region that is concentric with the first and second regions, wherein the first region, the second region, and the third region form alternating regions of near and far focus.

8 . The IOL of claim 1 , wherein the first selected wavelength and the second selected wavelength are at substantially a same wavelength in the visible spectrum.

9 . The IOL of claim 1 , wherein the first selected wavelength and the second selected wavelength are at a same wavelength in the visible spectrum.

10 . The IOL of claim 1 , wherein the same wavelength is approximately 555 nm.

11 . A method, comprising:

projecting light of a selected wavelength onto a first diffractive region and a second diffractive region of an IOL, the first region having a first diffractive optical power and the second region having a second diffractive optical power of a different magnitude than the first diffractive optical power;

diffracting substantially all light of a first selected wavelength projected onto the first region into a single non-zero order of diffraction; and

diffracting substantially all light of a second selected wavelength projected onto the second region into a single non-zero order of diffraction.

12 . The method of claim 11 , wherein the first selected wavelength and the second selected wavelength are at substantially a same wavelength in the visible spectrum.

13 . The method of claim 11 , wherein the first selected wavelength and the second selected wavelength are at a same wavelength in the visible spectrum.

14 . The method of claim 13 , wherein the same wavelength is approximately 555 nm.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
NOTICE OF SUCCESSION OF AGENCY Recorded Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
SECURITY AGREEMENT Recorded Sep 4, 2013
From: BAUSCH & LOMB INCORPORATED
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 031156/0508 →
RELEASE OF SECURITY INTEREST Recorded Aug 13, 2013
From: CITIBANK N.A., AS ADMINISTRATIVE AGENT
To: WP PRISM INC. (N/K/A BAUSCH & LOMB HOLDINGS INC.); BAUSCH & LOMB INCORPORATED; ISTA PHARMACEUTICALS
Reel/Frame 030995/0444 →
SECURITY AGREEMENT Recorded Aug 6, 2012
From: BAUSCH & LOMB INCORPORATED; EYEONICS, INC.
To: CITIBANK N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 028728/0645 →
RELEASE OF SECURITY INTEREST Recorded Aug 5, 2012
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 028726/0142 →
SECURITY AGREEMENT Recorded Nov 16, 2007
From: BAUSCH & LOMB INCORPORATED; B&L CRL INC.; B&L CRL PARTNERS L.P.; B & L DOMESTIC HOLDINGS CORP.; B&L FINANCIAL HOLDINGS CORP.; B&L SPAF INC.; B&L VPLEX HOLDINGS, INC.; BAUSCH & LOMB CHINA, INC.; BAUSCH & LOMB INTERNATIONAL INC.; BAUSCH & LOMB TECHNOLOGY CORPORATION; BAUSCH & LOMB REALTY CORPORATION; BAUSCH & LOMB SOUTH ASIA, INC.; SIGHT SAVERS, INC.; WILMINGTON MANAGEMENT CORP.; WILMINGTON PARTNERS L.P.; B&L MINORITY DUTCH HOLDINGS LLC; IOLAB CORPORATION; RHC HOLDINGS, INC.; WP PRISM, INC.
To: CREDIT SUISSE
Reel/Frame 020122/0722 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 1, 2007
From: ALTMANN, GRIFFITH E.
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 019370/0467 →